NHLBI TOPMed: Recipient Epidemiology and Donor Evaluation Study-III Brazil Sickle Cell Disease Cohort (REDS-BSCDC)
Anthropometry (2)
- HeightInEnrollment - Height measured at enrollment (phv00420321.v1.p1)
- WeightInEnrollment - Weight measured at enrollment (phv00420320.v1.p1)
Biomarkers (2)
- DiastolicBP - Diastolic blood pressure measured at enrollment (phv00420323.v1.p1)
- SystolicBP - Systolic blood pressure measured at enrollment (phv00420322.v1.p1)
Demographics (1)
- gender - Gender (phv00420326.v1.p1)
Sleep (1)
- OxygenSaturation - Oxygen saturation result measured at enrollment (phv00420324.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte Type (phv00420329.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00420328.v1.p1)
- Box_Location - Box location (phv00420334.v1.p1)
- Box_Number - Box number (phv00420333.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00420315.v1.p1)
- Funding_Source - Project funding source (phv00420335.v1.p1)
- HemoCenter - Enrollment Hemo Center (phv00420319.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00420331.v1.p1)
- HydroxyureaUse - Current use of hydroxyurea (phv00420325.v1.p1)
- IS_TUMOR - Tumor status (phv00420330.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00420327.v1.p1)
- SAMPLE_ID - Sample ID (phv00420317.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00420332.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00420338.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00420318.v1.p1)
- SUBJECT_ID - Subject ID (phv00420314.v1.p1)
- SUBJECT_ID - Subject ID (phv00420316.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00420336.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00420337.v1.p1)